 | • レポートコード：MRC2-11QY01503 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はヒドロキシプロゲステロンのグローバル市場について調査・分析したレポートです。種類別（経口、注射）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ヒドロキシプロゲステロンの競争状況、市場シェア ・世界のヒドロキシプロゲステロン市場：種類別市場規模 2015年-2020年（経口、注射） ・世界のヒドロキシプロゲステロン市場：種類別市場規模予測 2021年-2026年（経口、注射） ・世界のヒドロキシプロゲステロン市場：用途別市場規模 2015年-2020年（病院、クリニック） ・世界のヒドロキシプロゲステロン市場：用途別市場規模予測 2021年-2026年（病院、クリニック） ・北米のヒドロキシプロゲステロン市場分析：米国、カナダ ・ヨーロッパのヒドロキシプロゲステロン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのヒドロキシプロゲステロン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のヒドロキシプロゲステロン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのヒドロキシプロゲステロン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AMAG Pharmaceuticals、ANI Pharmaceuticals, Inc.、Mylan Institutional、Mcguff Pharmaceuticals Inc、Antibioticos Spa、Aspen Oss B.V.、Diosynth Bv、Naari Ag、Schering Ag、Steroid Spa、Sun Pharmaceutical、Symbiotec Pharmalab、Upjohn Co、Zhejiang Xianju Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Hydroxyprogesterone Market
The global Hydroxyprogesterone market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Hydroxyprogesterone Scope and Market Size
Hydroxyprogesterone market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hydroxyprogesterone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Hydroxyprogesterone market is segmented into
Oral
Injection
Segment by Application, the Hydroxyprogesterone market is segmented into
Hospitals
Clinics
Regional and Country-level Analysis
The Hydroxyprogesterone market is analysed and market size information is provided by regions (countries).
The key regions covered in the Hydroxyprogesterone market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Hydroxyprogesterone Market Share Analysis
Hydroxyprogesterone market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hydroxyprogesterone business, the date to enter into the Hydroxyprogesterone market, Hydroxyprogesterone product introduction, recent developments, etc.
The major vendors covered:
AMAG Pharmaceuticals
ANI Pharmaceuticals, Inc.
Mylan Institutional
Mcguff Pharmaceuticals Inc
Antibioticos Spa
Aspen Oss B.V.
Diosynth Bv
Naari Ag
Schering Ag
Steroid Spa
Sun Pharmaceutical
Symbiotec Pharmalab
Upjohn Co
Zhejiang Xianju Pharmaceutical
1 Study Coverage
1.1 Hydroxyprogesterone Product Introduction
1.2 Market Segments
1.3 Key Hydroxyprogesterone Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Hydroxyprogesterone Market Size Growth Rate by Type
1.4.2 Oral
1.4.3 Injection
1.5 Market by Application
1.5.1 Global Hydroxyprogesterone Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Hydroxyprogesterone Market Size, Estimates and Forecasts
2.1.1 Global Hydroxyprogesterone Revenue 2015-2026
2.1.2 Global Hydroxyprogesterone Sales 2015-2026
2.2 Global Hydroxyprogesterone, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Hydroxyprogesterone Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Hydroxyprogesterone Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Hydroxyprogesterone Competitor Landscape by Players
3.1 Hydroxyprogesterone Sales by Manufacturers
3.1.1 Hydroxyprogesterone Sales by Manufacturers (2015-2020)
3.1.2 Hydroxyprogesterone Sales Market Share by Manufacturers (2015-2020)
3.2 Hydroxyprogesterone Revenue by Manufacturers
3.2.1 Hydroxyprogesterone Revenue by Manufacturers (2015-2020)
3.2.2 Hydroxyprogesterone Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Hydroxyprogesterone Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Hydroxyprogesterone Revenue in 2019
3.2.5 Global Hydroxyprogesterone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Hydroxyprogesterone Price by Manufacturers
3.4 Hydroxyprogesterone Manufacturing Base Distribution, Product Types
3.4.1 Hydroxyprogesterone Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hydroxyprogesterone Product Type
3.4.3 Date of International Manufacturers Enter into Hydroxyprogesterone Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hydroxyprogesterone Market Size by Type (2015-2020)
4.1.1 Global Hydroxyprogesterone Sales by Type (2015-2020)
4.1.2 Global Hydroxyprogesterone Revenue by Type (2015-2020)
4.1.3 Hydroxyprogesterone Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Hydroxyprogesterone Market Size Forecast by Type (2021-2026)
4.2.1 Global Hydroxyprogesterone Sales Forecast by Type (2021-2026)
4.2.2 Global Hydroxyprogesterone Revenue Forecast by Type (2021-2026)
4.2.3 Hydroxyprogesterone Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Hydroxyprogesterone Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Hydroxyprogesterone Market Size by Application (2015-2020)
5.1.1 Global Hydroxyprogesterone Sales by Application (2015-2020)
5.1.2 Global Hydroxyprogesterone Revenue by Application (2015-2020)
5.1.3 Hydroxyprogesterone Price by Application (2015-2020)
5.2 Hydroxyprogesterone Market Size Forecast by Application (2021-2026)
5.2.1 Global Hydroxyprogesterone Sales Forecast by Application (2021-2026)
5.2.2 Global Hydroxyprogesterone Revenue Forecast by Application (2021-2026)
5.2.3 Global Hydroxyprogesterone Price Forecast by Application (2021-2026)
6 North America
6.1 North America Hydroxyprogesterone by Country
6.1.1 North America Hydroxyprogesterone Sales by Country
6.1.2 North America Hydroxyprogesterone Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Hydroxyprogesterone Market Facts & Figures by Type
6.3 North America Hydroxyprogesterone Market Facts & Figures by Application
7 Europe
7.1 Europe Hydroxyprogesterone by Country
7.1.1 Europe Hydroxyprogesterone Sales by Country
7.1.2 Europe Hydroxyprogesterone Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hydroxyprogesterone Market Facts & Figures by Type
7.3 Europe Hydroxyprogesterone Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Hydroxyprogesterone by Region
8.1.1 Asia Pacific Hydroxyprogesterone Sales by Region
8.1.2 Asia Pacific Hydroxyprogesterone Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Hydroxyprogesterone Market Facts & Figures by Type
8.3 Asia Pacific Hydroxyprogesterone Market Facts & Figures by Application
9 Latin America
9.1 Latin America Hydroxyprogesterone by Country
9.1.1 Latin America Hydroxyprogesterone Sales by Country
9.1.2 Latin America Hydroxyprogesterone Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Hydroxyprogesterone Market Facts & Figures by Type
9.3 Central & South America Hydroxyprogesterone Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Hydroxyprogesterone by Country
10.1.1 Middle East and Africa Hydroxyprogesterone Sales by Country
10.1.2 Middle East and Africa Hydroxyprogesterone Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Hydroxyprogesterone Market Facts & Figures by Type
10.3 Middle East and Africa Hydroxyprogesterone Market Facts & Figures by Application
11 Company Profiles
11.1 AMAG Pharmaceuticals
11.1.1 AMAG Pharmaceuticals Corporation Information
11.1.2 AMAG Pharmaceuticals Description and Business Overview
11.1.3 AMAG Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AMAG Pharmaceuticals Hydroxyprogesterone Products Offered
11.1.5 AMAG Pharmaceuticals Related Developments
11.2 ANI Pharmaceuticals, Inc.
11.2.1 ANI Pharmaceuticals, Inc. Corporation Information
11.2.2 ANI Pharmaceuticals, Inc. Description and Business Overview
11.2.3 ANI Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 ANI Pharmaceuticals, Inc. Hydroxyprogesterone Products Offered
11.2.5 ANI Pharmaceuticals, Inc. Related Developments
11.3 Mylan Institutional
11.3.1 Mylan Institutional Corporation Information
11.3.2 Mylan Institutional Description and Business Overview
11.3.3 Mylan Institutional Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Mylan Institutional Hydroxyprogesterone Products Offered
11.3.5 Mylan Institutional Related Developments
11.4 Mcguff Pharmaceuticals Inc
11.4.1 Mcguff Pharmaceuticals Inc Corporation Information
11.4.2 Mcguff Pharmaceuticals Inc Description and Business Overview
11.4.3 Mcguff Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Products Offered
11.4.5 Mcguff Pharmaceuticals Inc Related Developments
11.5 Antibioticos Spa
11.5.1 Antibioticos Spa Corporation Information
11.5.2 Antibioticos Spa Description and Business Overview
11.5.3 Antibioticos Spa Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Antibioticos Spa Hydroxyprogesterone Products Offered
11.5.5 Antibioticos Spa Related Developments
11.6 Aspen Oss B.V.
11.6.1 Aspen Oss B.V. Corporation Information
11.6.2 Aspen Oss B.V. Description and Business Overview
11.6.3 Aspen Oss B.V. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Aspen Oss B.V. Hydroxyprogesterone Products Offered
11.6.5 Aspen Oss B.V. Related Developments
11.7 Diosynth Bv
11.7.1 Diosynth Bv Corporation Information
11.7.2 Diosynth Bv Description and Business Overview
11.7.3 Diosynth Bv Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Diosynth Bv Hydroxyprogesterone Products Offered
11.7.5 Diosynth Bv Related Developments
11.8 Naari Ag
11.8.1 Naari Ag Corporation Information
11.8.2 Naari Ag Description and Business Overview
11.8.3 Naari Ag Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Naari Ag Hydroxyprogesterone Products Offered
11.8.5 Naari Ag Related Developments
11.9 Schering Ag
11.9.1 Schering Ag Corporation Information
11.9.2 Schering Ag Description and Business Overview
11.9.3 Schering Ag Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Schering Ag Hydroxyprogesterone Products Offered
11.9.5 Schering Ag Related Developments
11.10 Steroid Spa
11.10.1 Steroid Spa Corporation Information
11.10.2 Steroid Spa Description and Business Overview
11.10.3 Steroid Spa Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Steroid Spa Hydroxyprogesterone Products Offered
11.10.5 Steroid Spa Related Developments
11.1 AMAG Pharmaceuticals
11.1.1 AMAG Pharmaceuticals Corporation Information
11.1.2 AMAG Pharmaceuticals Description and Business Overview
11.1.3 AMAG Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AMAG Pharmaceuticals Hydroxyprogesterone Products Offered
11.1.5 AMAG Pharmaceuticals Related Developments
11.12 Symbiotec Pharmalab
11.12.1 Symbiotec Pharmalab Corporation Information
11.12.2 Symbiotec Pharmalab Description and Business Overview
11.12.3 Symbiotec Pharmalab Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Symbiotec Pharmalab Products Offered
11.12.5 Symbiotec Pharmalab Related Developments
11.13 Upjohn Co
11.13.1 Upjohn Co Corporation Information
11.13.2 Upjohn Co Description and Business Overview
11.13.3 Upjohn Co Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Upjohn Co Products Offered
11.13.5 Upjohn Co Related Developments
11.14 Zhejiang Xianju Pharmaceutical
11.14.1 Zhejiang Xianju Pharmaceutical Corporation Information
11.14.2 Zhejiang Xianju Pharmaceutical Description and Business Overview
11.14.3 Zhejiang Xianju Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Zhejiang Xianju Pharmaceutical Products Offered
11.14.5 Zhejiang Xianju Pharmaceutical Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Hydroxyprogesterone Market Estimates and Projections by Region
12.1.1 Global Hydroxyprogesterone Sales Forecast by Regions 2021-2026
12.1.2 Global Hydroxyprogesterone Revenue Forecast by Regions 2021-2026
12.2 North America Hydroxyprogesterone Market Size Forecast (2021-2026)
12.2.1 North America: Hydroxyprogesterone Sales Forecast (2021-2026)
12.2.2 North America: Hydroxyprogesterone Revenue Forecast (2021-2026)
12.2.3 North America: Hydroxyprogesterone Market Size Forecast by Country (2021-2026)
12.3 Europe Hydroxyprogesterone Market Size Forecast (2021-2026)
12.3.1 Europe: Hydroxyprogesterone Sales Forecast (2021-2026)
12.3.2 Europe: Hydroxyprogesterone Revenue Forecast (2021-2026)
12.3.3 Europe: Hydroxyprogesterone Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Hydroxyprogesterone Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Hydroxyprogesterone Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Hydroxyprogesterone Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Hydroxyprogesterone Market Size Forecast by Region (2021-2026)
12.5 Latin America Hydroxyprogesterone Market Size Forecast (2021-2026)
12.5.1 Latin America: Hydroxyprogesterone Sales Forecast (2021-2026)
12.5.2 Latin America: Hydroxyprogesterone Revenue Forecast (2021-2026)
12.5.3 Latin America: Hydroxyprogesterone Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Hydroxyprogesterone Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Hydroxyprogesterone Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Hydroxyprogesterone Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Hydroxyprogesterone Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Hydroxyprogesterone Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hydroxyprogesterone Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Hydroxyprogesterone Market Segments
Table 2. Ranking of Global Top Hydroxyprogesterone Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Hydroxyprogesterone Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Oral
Table 5. Major Manufacturers of Injection
Table 6. Global Hydroxyprogesterone Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Hydroxyprogesterone Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Hydroxyprogesterone Sales by Regions 2015-2020 (K Units)
Table 9. Global Hydroxyprogesterone Sales Market Share by Regions (2015-2020)
Table 10. Global Hydroxyprogesterone Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Hydroxyprogesterone Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Hydroxyprogesterone Sales Share by Manufacturers (2015-2020)
Table 13. Global Hydroxyprogesterone Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Hydroxyprogesterone by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hydroxyprogesterone as of 2019)
Table 15. Hydroxyprogesterone Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Hydroxyprogesterone Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Hydroxyprogesterone Price (2015-2020) (USD/Unit)
Table 18. Hydroxyprogesterone Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Hydroxyprogesterone Product Type
Table 20. Date of International Manufacturers Enter into Hydroxyprogesterone Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Hydroxyprogesterone Sales by Type (2015-2020) (K Units)
Table 23. Global Hydroxyprogesterone Sales Share by Type (2015-2020)
Table 24. Global Hydroxyprogesterone Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Hydroxyprogesterone Revenue Share by Type (2015-2020)
Table 26. Hydroxyprogesterone Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Hydroxyprogesterone Sales by Application (2015-2020) (K Units)
Table 28. Global Hydroxyprogesterone Sales Share by Application (2015-2020)
Table 29. North America Hydroxyprogesterone Sales by Country (2015-2020) (K Units)
Table 30. North America Hydroxyprogesterone Sales Market Share by Country (2015-2020)
Table 31. North America Hydroxyprogesterone Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Hydroxyprogesterone Revenue Market Share by Country (2015-2020)
Table 33. North America Hydroxyprogesterone Sales by Type (2015-2020) (K Units)
Table 34. North America Hydroxyprogesterone Sales Market Share by Type (2015-2020)
Table 35. North America Hydroxyprogesterone Sales by Application (2015-2020) (K Units)
Table 36. North America Hydroxyprogesterone Sales Market Share by Application (2015-2020)
Table 37. Europe Hydroxyprogesterone Sales by Country (2015-2020) (K Units)
Table 38. Europe Hydroxyprogesterone Sales Market Share by Country (2015-2020)
Table 39. Europe Hydroxyprogesterone Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Hydroxyprogesterone Revenue Market Share by Country (2015-2020)
Table 41. Europe Hydroxyprogesterone Sales by Type (2015-2020) (K Units)
Table 42. Europe Hydroxyprogesterone Sales Market Share by Type (2015-2020)
Table 43. Europe Hydroxyprogesterone Sales by Application (2015-2020) (K Units)
Table 44. Europe Hydroxyprogesterone Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Hydroxyprogesterone Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Hydroxyprogesterone Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Hydroxyprogesterone Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Hydroxyprogesterone Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Hydroxyprogesterone Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Hydroxyprogesterone Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Hydroxyprogesterone Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Hydroxyprogesterone Sales Market Share by Application (2015-2020)
Table 53. Latin America Hydroxyprogesterone Sales by Country (2015-2020) (K Units)
Table 54. Latin America Hydroxyprogesterone Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Hydroxyprogesterone Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Hydroxyprogesterone Revenue Market Share by Country (2015-2020)
Table 57. Latin America Hydroxyprogesterone Sales by Type (2015-2020) (K Units)
Table 58. Latin America Hydroxyprogesterone Sales Market Share by Type (2015-2020)
Table 59. Latin America Hydroxyprogesterone Sales by Application (2015-2020) (K Units)
Table 60. Latin America Hydroxyprogesterone Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Hydroxyprogesterone Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Hydroxyprogesterone Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Hydroxyprogesterone Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Hydroxyprogesterone Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Hydroxyprogesterone Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Hydroxyprogesterone Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Hydroxyprogesterone Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Hydroxyprogesterone Sales Market Share by Application (2015-2020)
Table 69. AMAG Pharmaceuticals Corporation Information
Table 70. AMAG Pharmaceuticals Description and Major Businesses
Table 71. AMAG Pharmaceuticals Hydroxyprogesterone Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. AMAG Pharmaceuticals Product
Table 73. AMAG Pharmaceuticals Recent Development
Table 74. ANI Pharmaceuticals, Inc. Corporation Information
Table 75. ANI Pharmaceuticals, Inc. Description and Major Businesses
Table 76. ANI Pharmaceuticals, Inc. Hydroxyprogesterone Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. ANI Pharmaceuticals, Inc. Product
Table 78. ANI Pharmaceuticals, Inc. Recent Development
Table 79. Mylan Institutional Corporation Information
Table 80. Mylan Institutional Description and Major Businesses
Table 81. Mylan Institutional Hydroxyprogesterone Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Mylan Institutional Product
Table 83. Mylan Institutional Recent Development
Table 84. Mcguff Pharmaceuticals Inc Corporation Information
Table 85. Mcguff Pharmaceuticals Inc Description and Major Businesses
Table 86. Mcguff Pharmaceuticals Inc Hydroxyprogesterone Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Mcguff Pharmaceuticals Inc Product
Table 88. Mcguff Pharmaceuticals Inc Recent Development
Table 89. Antibioticos Spa Corporation Information
Table 90. Antibioticos Spa Description and Major Businesses
Table 91. Antibioticos Spa Hydroxyprogesterone Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Antibioticos Spa Product
Table 93. Antibioticos Spa Recent Development
Table 94. Aspen Oss B.V. Corporation Information
Table 95. Aspen Oss B.V. Description and Major Businesses
Table 96. Aspen Oss B.V. Hydroxyprogesterone Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Aspen Oss B.V. Product
Table 98. Aspen Oss B.V. Recent Development
Table 99. Diosynth Bv Corporation Information
Table 100. Diosynth Bv Description and Major Businesses
Table 101. Diosynth Bv Hydroxyprogesterone Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Diosynth Bv Product
Table 103. Diosynth Bv Recent Development
Table 104. Naari Ag Corporation Information
Table 105. Naari Ag Description and Major Businesses
Table 106. Naari Ag Hydroxyprogesterone Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Naari Ag Product
Table 108. Naari Ag Recent Development
Table 109. Schering Ag Corporation Information
Table 110. Schering Ag Description and Major Businesses
Table 111. Schering Ag Hydroxyprogesterone Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Schering Ag Product
Table 113. Schering Ag Recent Development
Table 114. Steroid Spa Corporation Information
Table 115. Steroid Spa Description and Major Businesses
Table 116. Steroid Spa Hydroxyprogesterone Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Steroid Spa Product
Table 118. Steroid Spa Recent Development
Table 119. Sun Pharmaceutical Corporation Information
Table 120. Sun Pharmaceutical Description and Major Businesses
Table 121. Sun Pharmaceutical Hydroxyprogesterone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Sun Pharmaceutical Product
Table 123. Sun Pharmaceutical Recent Development
Table 124. Symbiotec Pharmalab Corporation Information
Table 125. Symbiotec Pharmalab Description and Major Businesses
Table 126. Symbiotec Pharmalab Hydroxyprogesterone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Symbiotec Pharmalab Product
Table 128. Symbiotec Pharmalab Recent Development
Table 129. Upjohn Co Corporation Information
Table 130. Upjohn Co Description and Major Businesses
Table 131. Upjohn Co Hydroxyprogesterone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Upjohn Co Product
Table 133. Upjohn Co Recent Development
Table 134. Zhejiang Xianju Pharmaceutical Corporation Information
Table 135. Zhejiang Xianju Pharmaceutical Description and Major Businesses
Table 136. Zhejiang Xianju Pharmaceutical Hydroxyprogesterone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. Zhejiang Xianju Pharmaceutical Product
Table 138. Zhejiang Xianju Pharmaceutical Recent Development
Table 139. Global Hydroxyprogesterone Sales Forecast by Regions (2021-2026) (K Units)
Table 140. Global Hydroxyprogesterone Sales Market Share Forecast by Regions (2021-2026)
Table 141. Global Hydroxyprogesterone Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 142. Global Hydroxyprogesterone Revenue Market Share Forecast by Regions (2021-2026)
Table 143. North America: Hydroxyprogesterone Sales Forecast by Country (2021-2026) (K Units)
Table 144. North America: Hydroxyprogesterone Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Europe: Hydroxyprogesterone Sales Forecast by Country (2021-2026) (K Units)
Table 146. Europe: Hydroxyprogesterone Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Asia Pacific: Hydroxyprogesterone Sales Forecast by Region (2021-2026) (K Units)
Table 148. Asia Pacific: Hydroxyprogesterone Revenue Forecast by Region (2021-2026) (US$ Million)
Table 149. Latin America: Hydroxyprogesterone Sales Forecast by Country (2021-2026) (K Units)
Table 150. Latin America: Hydroxyprogesterone Revenue Forecast by Country (2021-2026) (US$ Million)
Table 151. Middle East and Africa: Hydroxyprogesterone Sales Forecast by Country (2021-2026) (K Units)
Table 152. Middle East and Africa: Hydroxyprogesterone Revenue Forecast by Country (2021-2026) (US$ Million)
Table 153. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 154. Key Challenges
Table 155. Market Risks
Table 156. Main Points Interviewed from Key Hydroxyprogesterone Players
Table 157. Hydroxyprogesterone Customers List
Table 158. Hydroxyprogesterone Distributors List
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Hydroxyprogesterone Product Picture
Figure 2. Global Hydroxyprogesterone Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Product Picture
Figure 4. Injection Product Picture
Figure 5. Global Hydroxyprogesterone Sales Market Share by Application in 2020 & 2026
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Hydroxyprogesterone Report Years Considered
Figure 9. Global Hydroxyprogesterone Market Size 2015-2026 (US$ Million)
Figure 10. Global Hydroxyprogesterone Sales 2015-2026 (K Units)
Figure 11. Global Hydroxyprogesterone Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Hydroxyprogesterone Sales Market Share by Region (2015-2020)
Figure 13. Global Hydroxyprogesterone Sales Market Share by Region in 2019
Figure 14. Global Hydroxyprogesterone Revenue Market Share by Region (2015-2020)
Figure 15. Global Hydroxyprogesterone Revenue Market Share by Region in 2019
Figure 16. Global Hydroxyprogesterone Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Hydroxyprogesterone Revenue in 2019
Figure 18. Hydroxyprogesterone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Hydroxyprogesterone Sales Market Share by Type (2015-2020)
Figure 20. Global Hydroxyprogesterone Sales Market Share by Type in 2019
Figure 21. Global Hydroxyprogesterone Revenue Market Share by Type (2015-2020)
Figure 22. Global Hydroxyprogesterone Revenue Market Share by Type in 2019
Figure 23. Global Hydroxyprogesterone Market Share by Price Range (2015-2020)
Figure 24. Global Hydroxyprogesterone Sales Market Share by Application (2015-2020)
Figure 25. Global Hydroxyprogesterone Sales Market Share by Application in 2019
Figure 26. Global Hydroxyprogesterone Revenue Market Share by Application (2015-2020)
Figure 27. Global Hydroxyprogesterone Revenue Market Share by Application in 2019
Figure 28. North America Hydroxyprogesterone Sales Growth Rate 2015-2020 (K Units)
Figure 29. North America Hydroxyprogesterone Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Hydroxyprogesterone Sales Market Share by Country in 2019
Figure 31. North America Hydroxyprogesterone Revenue Market Share by Country in 2019
Figure 32. U.S. Hydroxyprogesterone Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.S. Hydroxyprogesterone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Hydroxyprogesterone Sales Growth Rate (2015-2020) (K Units)
Figure 35. Canada Hydroxyprogesterone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Hydroxyprogesterone Market Share by Type in 2019
Figure 37. North America Hydroxyprogesterone Market Share by Application in 2019
Figure 38. Europe Hydroxyprogesterone Sales Growth Rate 2015-2020 (K Units)
Figure 39. Europe Hydroxyprogesterone Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Hydroxyprogesterone Sales Market Share by Country in 2019
Figure 41. Europe Hydroxyprogesterone Revenue Market Share by Country in 2019
Figure 42. Germany Hydroxyprogesterone Sales Growth Rate (2015-2020) (K Units)
Figure 43. Germany Hydroxyprogesterone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Hydroxyprogesterone Sales Growth Rate (2015-2020) (K Units)
Figure 45. France Hydroxyprogesterone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Hydroxyprogesterone Sales Growth Rate (2015-2020) (K Units)
Figure 47. U.K. Hydroxyprogesterone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Hydroxyprogesterone Sales Growth Rate (2015-2020) (K Units)
Figure 49. Italy Hydroxyprogesterone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Hydroxyprogesterone Sales Growth Rate (2015-2020) (K Units)
Figure 51. Russia Hydroxyprogesterone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Hydroxyprogesterone Market Share by Type in 2019
Figure 53. Europe Hydroxyprogesterone Market Share by Application in 2019
Figure 54. Asia Pacific Hydroxyprogesterone Sales Growth Rate 2015-2020 (K Units)
Figure 55. Asia Pacific Hydroxyprogesterone Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Hydroxyprogesterone Sales Market Share by Region in 2019
Figure 57. Asia Pacific Hydroxyprogesterone Revenue Market Share by Region in 2019
Figure 58. China Hydroxyprogesterone Sales Growth Rate (2015-2020) (K Units)
Figure 59. China Hydroxyprogesterone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Hydroxyprogesterone Sales Growth Rate (2015-2020) (K Units)
Figure 61. Japan Hydroxyprogesterone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Hydroxyprogesterone Sales Growth Rate (2015-2020) (K Units)
Figure 63. South Korea Hydroxyprogesterone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Hydroxyprogesterone Sales Growth Rate (2015-2020) (K Units)
Figure 65. India Hydroxyprogesterone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Hydroxyprogesterone Sales Growth Rate (2015-2020) (K Units)
Figure 67. Australia Hydroxyprogesterone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Hydroxyprogesterone Sales Growth Rate (2015-2020) (K Units)
Figure 69. Taiwan Hydroxyprogesterone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Hydroxyprogesterone Sales Growth Rate (2015-2020) (K Units)
Figure 71. Indonesia Hydroxyprogesterone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Hydroxyprogesterone Sales Growth Rate (2015-2020) (K Units)
Figure 73. Thailand Hydroxyprogesterone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Hydroxyprogesterone Sales Growth Rate (2015-2020) (K Units)
Figure 75. Malaysia Hydroxyprogesterone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Hydroxyprogesterone Sales Growth Rate (2015-2020) (K Units)
Figure 77. Philippines Hydroxyprogesterone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Hydroxyprogesterone Sales Growth Rate (2015-2020) (K Units)
Figure 79. Vietnam Hydroxyprogesterone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Hydroxyprogesterone Market Share by Type in 2019
Figure 81. Asia Pacific Hydroxyprogesterone Market Share by Application in 2019
Figure 82. Latin America Hydroxyprogesterone Sales Growth Rate 2015-2020 (K Units)
Figure 83. Latin America Hydroxyprogesterone Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Hydroxyprogesterone Sales Market Share by Country in 2019
Figure 85. Latin America Hydroxyprogesterone Revenue Market Share by Country in 2019
Figure 86. Mexico Hydroxyprogesterone Sales Growth Rate (2015-2020) (K Units)
Figure 87. Mexico Hydroxyprogesterone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Hydroxyprogesterone Sales Growth Rate (2015-2020) (K Units)
Figure 89. Brazil Hydroxyprogesterone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Hydroxyprogesterone Sales Growth Rate (2015-2020) (K Units)
Figure 91. Argentina Hydroxyprogesterone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Hydroxyprogesterone Market Share by Type in 2019
Figure 93. Latin America Hydroxyprogesterone Market Share by Application in 2019
Figure 94. Middle East and Africa Hydroxyprogesterone Sales Growth Rate 2015-2020 (K Units)
Figure 95. Middle East and Africa Hydroxyprogesterone Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Hydroxyprogesterone Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Hydroxyprogesterone Revenue Market Share by Country in 2019
Figure 98. Turkey Hydroxyprogesterone Sales Growth Rate (2015-2020) (K Units)
Figure 99. Turkey Hydroxyprogesterone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Hydroxyprogesterone Sales Growth Rate (2015-2020) (K Units)
Figure 101. Saudi Arabia Hydroxyprogesterone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Hydroxyprogesterone Sales Growth Rate (2015-2020) (K Units)
Figure 103. U.A.E Hydroxyprogesterone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Hydroxyprogesterone Market Share by Type in 2019
Figure 105. Middle East and Africa Hydroxyprogesterone Market Share by Application in 2019
Figure 106. North America Hydroxyprogesterone Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 107. North America Hydroxyprogesterone Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe Hydroxyprogesterone Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. Europe Hydroxyprogesterone Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific Hydroxyprogesterone Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Asia Pacific Hydroxyprogesterone Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America Hydroxyprogesterone Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Latin America Hydroxyprogesterone Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa Hydroxyprogesterone Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Middle East and Africa Hydroxyprogesterone Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed
ヒドロキシプロゲステロンカプロエートの世界市場（～2026年） Market Analysis and Insights: Global Hydroxyprogesterone Caproate Market The global Hydroxyprogesterone Caproate market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Hydroxyprogesterone Caproate Scope and Market Size Hydrox…- 口腔粘膜炎の世界市場（～2026年） Mucositis occurs when cancer treatments break down the rapidly divided epithelial cells lining the gastro-intestinal tract (which goes from the mouth to the anus), leaving the mucosal tissue open to ulceration and infection. Mucosal tissue, also known as mucosa or the mucous membrane, lines all body…
- 口腔カンジダ症の世界市場（～2026年） Oral thrush occurs when a yeast infection develops on the inside of mouth and on tongue. This condition is also known as oral candidiasis, oropharyngeal candidiasis, or, simply, thrush. The Candida albicans fungus causes oral thrush. A small amount of this fungus normally lives in your mouth without…
- 口腔がん治療の世界市場（～2026年） Oral cancer, also known as mouth cancer, is a type of head and neck cancer and is any cancerous tissue growth located in the oral cavity. It may arise as a primary lesion originating in any of the tissues in the mouth, by metastasis from a distant site of origin, or by extension from a neighboring a…
- 医療用射出成形の世界市場（～2026年） Market Analysis and Insights: Global Medical Injection Molding Market The global Medical Injection Molding market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, th…